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Abstract
Background: Working women of childbearing age are a vital part of the population. Following childbirth, this
group of women can experience a myriad of physical and mental health problems that can interfere with their
ability to work. Currently, there is little known about cost-effective post-partum interventions to prevent work
disability. The purpose of the study was to evaluate whether supervisor telephone contact (STC) during maternity
leave is cost-effective from a societal perspective in reducing sick leave and improving quality-adjusted life years
(QALYs) compared to common practice (CP).
Methods: We conducted an economic evaluation alongside a randomized controlled trial. QALYs were measured
by the EuroQol 5-D, and sick leave and presenteeism by the Health and work Performance Questionnaire. Resource
use was collected by questionnaires. Data were analysed according to intention-to-treat. Missing data were
imputed via multiple imputation. Uncertainty was estimated by 95% confidence intervals, cost-utility planes and
curves, and sensitivity analyses.
Results: 541 working women from 15 companies participated. Response rates were above 85% at each
measurement moment. At the end of the follow-up, no statistically significant between-group differences in QALYs,
mean hours of sick leave or presenteeism or costs were observed. STC was found to be less effective and more
costly. For willingness-to-pay levels from €0 through €50,000, the probability that STC was cost-effective compared
to CP was 0.2. Overall resource use was low. Mean total costs were €3678 (95% CI: 3386; 3951). Productivity loss
costs represented 37% of the total costs and of these costs, 48% was attributable to sick leave and 52% to work
presenteeism. The cost analysis from a company’s perspective indicated that there was a net cost associated with
the STC intervention.
Conclusions: STC was not cost-effective compared to common practice for a healthy population of working
mothers; therefore, implementation is not indicated. The cost-utility of STC for working mothers with more severe
post-partum health problems, however, needs to be investigated. Work presenteeism accounted for half of the
total productivity loss and warrants attention in future studies.
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Background
Worldwide working women of childbearing age are a
vital part of the population. Following childbirth, this
group of women can experience a myriad of physical
and mental health problems that can interfere with their
ability to work [1-3]. Yet, discussions surrounding post-
partum return-to-work and maternal health are infre-
quent [4]. Sick leave is common. Van Beukering [2]
reported that - following maternity leave - 29% of Dutch
working women took two or more weeks of sick leave.
In 55% of these cases, sick leave periods exceeded 12
weeks. Furthermore, Cuelenaere et al. [5] reported that
the annual percentage of women with postpartum sick
leave who qualified for work disability benefits was
higher than the rest of the working population: 5% ver-
sus 1.5%. These physical and mental health problems
may also interfere with a woman’s ability to work once
she has returned to the workplace, that is, result in
work presenteeism [6]. While statistics on work presen-
teeism among women following childbirth are currently
lacking, there is growing evidence of work presenteeism
among workers with health problems such as back or
other musculoskeletal pain, fatigue and depression [7,8].
Given the similarity with the types of health problems
faced by women following childbirth, the existence of
work presenteeism is plausible.
In practice, post-partum health care by the midwife,
obstetrician/gynaecologist or general practitioner covers
the first six weeks and is focused on the recovery of the
women’s reproductive system, not on physical or mental
health barriers to return-to-work. In the Netherlands,
maternity leave is 16 weeks long with full pay, and typi-
cally divided into 4-6 weeks before the delivery date and
10-12 weeks thereafter. Traditionally, Dutch working
women have received little active support by occupa-
tional health physicians during the post-partum period
[9], and occupational health case management during
the 10-12 week period after childbirth remains poorly
defined. Occupational health physicians are consulted
when return-to-work at the end of maternity leave per-
iod has been postponed by two to eight weeks of sick
leave. This can result in a situation of non-treatment
and prolonged sick leave. The former is paired with a
higher risk for chronicity and the latter is associated
with a reduced probability of return-to-work. Currently,
there is little known about cost-effective post-partum
interventions that can help prevent work disability.
While the role of supervisors in facilitating return-to-
work of employees on sick leave and case management
in The Netherlands is legislated [10], the scope excludes
involvement during maternity leave. Previous research
has shown that supervisors can play a key role in facili-
tating return-to-work [11]. As such, an intervention in
which supervisors make contact with workers during
maternity leave was developed and evaluated with the
hypothesis that this would reduce sick leave after child-
birth [12]. The objective of this study was to determine
whether supervisor telephone contact was cost-effective
from a societal perspective in reducing post-partum sick
leave and improving health-related quality of life com-
pared to common practice. We also described the
resource use, productivity loss and associated costs of
this study population during the first year post-partum.
Methods
Study design
This was an economic evaluation alongside a rando-
mized control trial [12]. We selected a societal perspec-
tive because in The Netherlands, current legislation
divides the financial responsibility for sick leave benefits
between social security (i.e. when sick leave is subse-
quent to maternity leave) and companies (i.e. when sick
leave occurs after a period of return to work following
maternity leave). Participants were followed for
52-weeks post-partum. The protocol was approved by
the Medical Ethics Committee of the VU University
Medical Centre, Amsterdam, The Netherlands. We
obtained written informed consent from all participants.
Participant recruitment
The sample size calculation was based on an expected
10% decrease in the number of women taking sick leave
at the end of maternity leave, a power of 80% and an
alpha-level of 0.05. A total of 550 pregnant working
women were needed.
The recruitment procedure consisted of two steps: 1.
recruitment of companies; and 2. recruitment of preg-
nant workers within these companies. For practical rea-
sons, we aimed our recruitment at large companies with
a predominantly female workforce. Based on reports of
higher sick leave rates before and after maternity leave
in the health care sector [2], health care providers (e.g.
hospitals, home health and occupational health service
companies) were over-sampled.
The recruitment of pregnant workers took place from
January 1, 2004 through March 31, 2006. Within each
participating company, the recruitment procedure was
initiated by the human resource departments. When
pregnant workers submitted requests for maternity
leave, they received an information package about the
study: letter of invitation, a study leaflet, two response
cards, and a return envelope. If a woman returned a
completed ‘yes’ response card, then researchers con-
tacted her to verify eligibility, obtain informed consent
and conduct the baseline measurement.
The inclusion criteria were: 1. aged 18 through
45 years; 2. employed a minimum of 12 hours per week;
and 3. clear intention to return-to-work after maternity
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leave to the same employer for a minimum of 12 hours
per week and for a minimum period of 6 months. The
exclusion criteria were: 1. miscarriage; 2. delivery before
34 weeks; 3. a request for full work-disability benefits
submitted; 4. receipt of full work-disability benefits; and
5. uncertainty or clear intention not to return the same
employer after maternity leave.
Randomization & blinding
In order to prevent contamination, randomization took
place at the level of the supervisor. For each participat-
ing company, a randomization list was computer-gen-
erated by an independent statistician assuring
concealment of treatment allocation. When partici-
pants were 35 weeks pregnant, supervisors were rando-
mized in blocks of four where each block contained
two intervention and two control group allocations.
Blocks of four were chosen because of the uncertainty
in how many employees of each company would parti-
cipate and some companies had a small number of
employees. Supervisors and participants in the control
group and data entry assistants were blinded to group
allocation. Blinding during the data analysis was guar-
anteed by means of coded patient, supervisor and com-
pany data.
The interventions
Supervisor telephone contact (STC)
The aim of the STC intervention was to prevent pro-
longed non-treatment of health problems that could
delay return-to-work following the end of maternity
leave by instigating the involvement of occupational
health services 6-12 weeks earlier than in the usual
situation. At 6-weeks post-partum, supervisors con-
tacted their employees to conduct a standardized inter-
view in order to identify health problems that may be
barriers to RTW after the official end of maternity
leave. If such health problems were identified, the sup-
port of the occupational health services was offered.
This telephone interview was in addition to the usual
congratulatory telephone calls, cards and visits. Supervi-
sors received written and oral instruction about their
role as case managers. At 6-weeks post-partum, respec-
tive supervisors received e-mail notification to carry out
this intervention.
Common practice (CP)
In CP, there was no structured contact by supervisors to
address health barriers to return-to-work during the
maternity leave period. Health problems and delays in
return-to-work may be discussed ad hoc during the
maternity leave or for the first time at the end of the
maternity leave period, at which time occupational
health services may be offered. Congratulatory telephone
calls, cards and visits took place as usual.
Data collection and valuation
We collected cost data related to the health care sector,
other sector and patient/family resource use using ques-
tionnaires at 6-, 12-, 18-, 24- and 52-weeks post-partum.
With the exception of the 52-week post-partum mea-
surement moment, the recall period for questionnaires
was six weeks; at 52-weeks, the recall period was four
weeks. With regards to productivity loss, we collected
data on both sick leave and work presenteeism (i.e.
decreased work performance due to a health problem)
using the Health and work Performance Questionnaire
(HPQ) [13] at 18-, 24- and 52-weeks post-partum. Data
on the use of parental leave and the number of hours
taken were also collected.
We collected extra cost data at 30-, 36-, 42- and
48-weeks post-partum if women reported consumed
health care resources, reported sick leave or work presen-
teeism, or reported still not back to her ‘old self’ in the
preceding measurement period. Otherwise, we did not
send out extra questionnaires as we assumed the women
were healthy and health care resources would not be
consumed nor that productivity loss would occur.
We measured health-related quality of life using the
EuroQol-5D [14] questionnaire at 6-, 12-, 24- and 52-
weeks post-partum. Utilities were determined by Dutch
tariffs as opposed to the original UK tariffs, given differ-
ences in health-related social preferences between the
countries. The Dutch tariffs were developed using the
time-trade off method where the anchors where 0 =
death and 1 = full health [15,16]. Quality-adjusted life
years (QALYs) were computed by multiplying the utili-
ties by the time spent in the given health state, and then
linearly interpolating the transitions between measured
health states [17].
Wherever possible, we determined costs by multiply-
ing the respective units of resource use by standard
price weights according to the Dutch Manual for Cost-
ing [18]. If standard price weights were not available, we
used tariffs or an average price according to providers
or professional organization. We calculated medication
costs using unit prices published by the Royal Dutch
Society for Pharmacy [19]. Productivity loss costs due to
sick leave were estimated using the Friction Cost
Method (FCM) and the Human Capital Approach
(HCA). For the FCM estimation, we used a friction per-
iod of 154 days and an elasticity of 0.8. Because follow-
up was limited to one year, we did not discount the
costs or outcomes [18]. Costs were reported in Euros
and the index year was 2006.
Data analysis
We analysed the data according to the intention-to-treat
principle. There were 9 women who were lost-to-follow-
up after randomization (STC = 5; CP = 4) for the
Uegaki et al. BMC Public Health 2011, 11:57
http://www.biomedcentral.com/1471-2458/11/57
Page 3 of 12
following reasons: problems with the questionnaire
(CP = 3), baby died (STC = 1), baby in hospital (STC =
1), no time (STC = 1; CP = 1), and no reason reported
(STC = 2). Because cost and health-related quality of
life data were not available for any of these subjects, we
had to exclude them from the analyses. Twenty women
became pregnant for a second time during the follow-up
period; we included these women in the analysis, but
treated the data following the time of second pregnancy
as missing.
First, we analysed utilities and resource utilization
rates using available data. Second, we determined mean
units of resource use using complete cases. Descriptive
analyses of utilities and resource use for each group and
between-group differences were conducted in SPSS ver-
sion 15.0. Third, we conducted the main cost, effect and
cost-utility analyses after imputing partially missing data
with a multiple imputation (MI) procedure based on
Multivariate Imputation by Chained Equations (MICE)
[20-23]. We defined the incremental cost-utility ratio
(ICUR) as the difference in total costs (i.e. TCFCM, the
sum of health care sector, other sector, patient/family,
intervention and productivity loss costs estimated by the
FCM) divided by the difference in QALYs. Baseline
characteristics were comparable between the groups,
therefore, we did not adjust our analyses for potential
confounding. Also, we conducted conventional, uncor-
rected analyses because there was no effect of clustering
at the supervisor or company levels. Finally, because
there were no differences in effect between the STC and
CP groups, we pooled resource use data from both
groups to gain insight into resource use and costs dur-
ing the first 52-weeks post-partum.
In the MI procedure, five imputed data sets were gen-
erated, each of which were analysed separately. We ana-
lysed the mean QALY differences parametrically [24].
The 95% confidence intervals around the mean cost dif-
ferences and ICUR differences were obtained using an
approximated bias-corrected (ABC) bootstrapping pro-
cedure with 1000 replications [25,26]. We applied
Rubin’s rules to obtain the pooled estimates of mean
costs and QALYs, mean cost and QALY differences and
95% confidence intervals. To gain insight into the uncer-
tainty around the pooled mean ICUR from the CUA,
we plotted the bootstrapped cost-effect pairs in a cost-
utility plane [27] and generated an acceptability curve
[28]. The multiple imputation procedure and analyses
of costs, effects and cost-utility were conducted in the
software, R [29].
Sensitivity analysis
We conducted three sensitivity analyses to test the
robustness of our main findings. First, we repeated the
main CUA in which the total costs included productiv-
ity loss costs estimated via the HCA. Second, we
conducted the CUA after excluding the 20 women who
became pregnant for a second time during the follow-
up period. Third, we repeated the CUA using only
complete cases.
Results
Participants and data availability
We invited 93 companies to participate in the study; 15
agreed. These 15 companies employed a range of 391 to
52,481 workers, and represented the health care (N = 9),
service (N = 5) and government (N = 1) sectors of
industry. Within these 15 companies, an estimated 1800
to 2500 working expectant mothers were invited to par-
ticipate in the study. A total of 416 supervisors were
randomized and 541 women participated in the study
(figure 1). Baseline characteristics of the women in the
two groups were similar (table 1).
The response rates for both groups were similar at
each measurement moment and ranged between 85%
and 98%. Both groups had a similar number of women
who had complete cost and QALY data: STC = 200
(75%); CP = 210 (76%). Baseline characteristics of the
complete cases and women with second pregnancies
were comparable between the groups. Except for a
small, statistically significant between-group difference
in the predominant type of work among women lost-to-
follow-up, baseline characteristics of women lost-to-
follow-up were similar. There was a small, statistically
significant difference in education level between com-
plete cases and those with incomplete data.
The proportion of women delivering at home versus
in the hospital were comparable between the groups
(STC: 88/259, 34%; CP: 84/259, 31%; Total: 172/530,
32.5%). There were no statistically significant between-
group differences in the mean hours of parental leave
(mean hours: STC = 114, S.D. = 158; CP = 120, S.D. =
177) nor proportion of women taking parental leave
after the end of maternity leave (Proportion: STC = 91/
206, 44%, CP = 99/218, 45%; mean hours: STC = 114, S.
D. = 158; CP = 120, S.D. = 177).
Resource use
Resource use per group and pooled data during the first
52-week post-partum period are presented in table 2.
Rates of resource utilization were similar between the
groups, except for the numbers visiting a psychologist
(STC: 9/204, 4.4%; CP: 2/215, 0.9%; p = 0.03) and physi-
cal therapist (STC: 36/204, 17.6%; CP: 22/215, 10.5%;
p = 0.03). There were no statistically significant
between-group differences in terms of units of resource
consumption.
During the first 52-weeks post-partum, the top five
most commonly used resources were: 1. maternity aid
care (98%); 2. medications or assistive devices (75%); 3.
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informal care by partner (58%); 4. GP consults (57%);
and 5. work presenteeism (46%). Less than 10% of the
women used occupational health services.
The top five mean volumes of consumed resources
were: 1. informal care by partner (42.5 hours); 2. mater-
nity aid care (39.6 hours); 3. productivity loss due to
work presenteeism (21.7 hours); 4. productivity loss due
to sick leave (20.4 hours); and 5. informal care by
family/friends/volunteers (15.4 hours).
Costs, effects and cost-utility analysis
At the end of the follow-up period, there were no statis-
tically significant between-group differences in QALYs
(STC mean = 0.928, S.D. = 0.094; CP mean = 0.935,
S.D.= 0.087; mean difference = -0.007, 95% CI: -0.023;
0.009). Also, the groups did not differ in terms of mean
number of sick leave hours (STC = 26.1, S.D. = 66.3;
CP = 24.6, S.D. = 65.2; mean difference = 1.5, 95%
CI: -10.1; 13.0), work presenteeism hours (STC = 24.1,
Respond to invitation
N=1218
Invited to participate 
N >1800-2500
Inclusion in study N=541
Supervisors randomized N=418
STC
Supervisors N=208
Workers N=265
CP
Supervisor N=210
Workers N=276Dropouts between baseline 
& 12-month follow-up N=28
Baby died N=1
Baby in hospital N=1
No time N=1
No reason N=22
Finds it enough N=3
Cases with 2nd pregnancy 
during 12-mo. follow-up N=8
Cases with partially missing
data between baseline & 12-
mo. N=29 
Available data between baseline & 
12-month follow-up: STC
Utility : 6-week PP  N=257 (97%)
             : 12-week PP N=254 (96%)
             : 24-week PP N=245 (93%)
             : 52-week PP N=226 (85%)
Resource use: 
: 6-week PP N=259 (98%)
: 12-week PP N=254 (96%)
: 18-week PP N=247 (93%)
: 24-week PP N=246 (93%)
: 30-week PP N=235 (89%)
: 36-week PP N=230 (87%)
: 42-week PP N=230 (87%) 
: 48-week PP N=229 (86%)
: 52-week PP N=228 (86%)
Available data between baseline & 
12-month follow-up: CP
Utility : 6-week PP  N=269 (98%)
             : 12-week PP N=265 (96%)
             : 24-week PP N=255 (92%)
             : 52-week PP N=239 (87%)
Resource use: 
: 6-week PP N=271 (98%)
: 12-week PP N=268 (97%)
: 18-week PP N=255 (92%)
: 24-week PP N=255 (92%)
: 30-week PP N=250 (91%)
: 36-week PP N=245 (89%)
: 42-week PP N=244 (88%) 
: 48-week PP N=242 (88%)
: 52-week PP N=242 (88%)
Complete data: STC
QALY  N=214 (81%)
Health care, other & patient/family 
resource use  N=204 (77%)
Productivity loss  N=206 (78%)
Cost-utility analysis N=200 (75%)
Complete data: CP
QALY   N=226 (82%)
Health care, other & patient/family 
resource use  N=214 (78%)
Productivity loss N=218 (79%)
Cost-utility analysis N=210 (76%)
Dropouts between baseline 
& 12-month follow-up N=27 
Problems with 
questionnaire N=4
No time N=3
No reason N=19
Finds it enough N=1
Cases with 2nd pregnancy 
during 12-mo. follow-up 
N=12
Cases with partially missing
data between baseline & 12-
mo. N= 27 
Excluded N=677
Refused to participate 
N=574
Did not meet inclusion 
criteria N=47
Response too late N=23
Aversion against 
intervention N=7
Other reasons N=26
Figure 1 Patient flow chart and data availability for Supervisor telephone contact (STC) and common practice (CP) between baseline
and the 12-month follow-up.
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S.D. = 36.7; CP = 20.7, S.D. = 29.8; mean difference =
3.4, 95% CI: -2.2; 9.1) or total productivity loss hours
(STC = 50.2, S.D. = 84.2; CP = 45.3, S.D. = 77.6; mean
difference = 4.9, 95% CI: -9.1; 18.9).
Mean costs per group, mean differences and pooled
costs are presented in table 3. Health care sector costs
represent medical costs covered under basic health
insurance for all Dutch citizens. Other sector costs
represent medical costs covered by companies or sup-
plemental insurance. Patient and family costs represent
non-medical costs paid out-of-pocket. Productivity
loss costs represent costs due to sick leave and work-
presenteeism. There were no statistically significant
between-group cost differences for any of the compo-
nent or total costs at the end of follow-up. The STC
did not result in any cost savings in terms of reduced
sick leave or work presenteeism compared to common
practice. Taken together, health care sector costs
accounted for 46.4% of the total costs, productivity
loss costs for 36.8%, patient/family costs for 16.5% and
other sector costs for 0.3%. Of the total productivity
loss costs, 48% was attributable to sick leave and 52%
to work presenteeism.
The joint cost-QALY pairs were distributed around all
four quadrants of the cost-utility plane. The majority of
the joint cost-QALY pairs and the mean ICUR were
located in the northwest quadrant indicating that the
intervention was less effective and more costly (figure 2).
For willingness-to-pay levels from €0 through €50,000,
there was a 20% chance of the STC intervention being
more cost-effective than common practice (cost-effective
acceptability curve not shown). Findings of all three sen-
sitivity analyses were in the same direction as the main
analysis (table 4).
Discussion
In this study, we evaluated the cost-utility of a supervi-
sor telephone contact intervention during maternity
leave with common practice among working mothers.
The results demonstrate that the intervention was
neither clinically nor economically superior to com-
mon practice. Therefore, implementation is not indi-
cated. We pooled the data of the two groups to gain
insight into the resource use during the first year post-
partum. The proportion of study population giving
birth in the hospital (67.5%) or at home (32.5%) was
Table 1 Baseline demographics, sick leave, health care use during first 6-weeks post-partum and utility for each
group: Supervisor telephone contact (STC) and Common Practice (CP)
Patients baseline measures STC (N = 265) CP (N = 276)
Mean age in years (S.D.; range) 32 (4.0; 19-45) 32 (4.3; 19-42)
Marital status, N (%) Single/Divorced 6 (2%) 8 (3%)
Common law/Married 259 (98%) 268 (97%)
Level of education, N (%) Low 25 (9%) 24 (9%)
Intermediate 87 (33%) 96 (35%)
High 153 (58%) 156 (57%)
1st pregnancy, N (%) 126 (48%) 133 (48%)
Hours worked per week, N (%) 12-23 64 (24%) 61 (22%)
24-35 122 (46%) 145 (53%)
> 36 79 (30%) 70 (25%)
Predominant type of work, N (%) Seated 94 (36%) 77 (28%)
Standing 58 (22%) 71 (25%)
Hand 109 (41%) 115 (42%)
Heavy 4 (2%) 13 (5%)
Pre-partum sick leave hours, mean (S.D.) 1 year before pregnancy 69 (155) * 66 (147) *
Pregnancy until start of maternity leave 112 (158) * 109 (178) *
Health care use, mean (S.D.) General practitioner 0.3 (0.7) † 0.3 (0.6) †
Midwife 0.2 (0.5) † 0.3 (0.7) †
Gynaecologist 0.2 (0.5) † 0.2 (0.5) †
Post-partum home care 40.0 (19.5) ‡ 39.3 (19.2) ‡
Partner 27.2 (43.3) ‡ 28.3 (45.6) ‡
Family/friends/volunteers 8.1 (21.4) ‡ 11.7 (25.4) ‡
Utility, mean (S.D.; range) 0.92 (0.12; 0.31-1.0) ¶ 0.91 (0.13; 0.17-1.0 ) ¶
* N for pre-partum sick leave based on company data: STC = 263; CP = 274; † Units of health care use are reported in the number of consultations. Available
data at baseline for STC was N = 259 and CP was N = 271. ‡ Units of health care use are reported in the number of hours. Available data at baseline for STC was
N = 259 and CP was N = 271. ¶ Available data at baseline for STC: N = 257 (97%) and CP: N = 269 (97%).
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Table 2 List of resources with respective price weights, observed resource use for each group during the pre- and post-intervention periods, and pooled
values for the total study population during the first 52 week post-partum period
Pre-intervention period
(1st 6 weeks post-partum)*
Post-intervention follow-up (6-52 weeks post-partum)* 52-weeks post-partum*
STC CP STC CP Pooled total
HEALTH CARE SECTOR Units Price weight
(in €)
% Mean (S.D.) % Mean (S.D.) % Mean (S.D.) % Mean (S.D.) % Mean (S.D)
General practitioner [No. of consults] 21.03 † 23 0.3 (0.7) 23 0.3 (0.6) 49 1.2 (1.9) 53 1.1 (1.6) 57 1.5 (2.0)
[No. of tel. consults] 10.51 † 14 0.2 (0.6) 17 0.2 (0.5) 16 0.3 (0.7) 19 0.3 (0.8) 29 0.5 (1.0)
[No. of house calls] 42.05 † 8 0.1 (0.4) 12 0.2 (0.7) 3 <0.1 (0.2) 2 <0.1 (0.1) 13 0.2 (0.6)
Nurse practitioner [No. of consults] 21.03 † 1 <0.1 (0.1) 3 0.1 (0.4) 3 <0.1 (0.2) 4 0.1 (0.4) 6 0.1 (0.4)
[No. of tel. consults] 10.51 † 2 <0.1 (0.2) 3 <0.1 (0.3) 3 <0.1 (0.2) 1 <0.1 (0.2) 5 0.1 (0.3)
[No. of house calls] 42.05 † 3 0.1 (0.4) 3 <0.1 (0.3) 0 0 (0) 0 0 (0) 2 <0.1 (0.2)
Midwife [No. of consults] 12.13 † 17 0.2 (0.5) 19 0.3 (0.7) 6 0.1 (0.2) 9 0.1 (0.3) 23 0.3 (0.7)
[No. of tel. consults] 6.06 † 4 0.1 (0.3) 5 0.1 (0.3) 0 0 (0) 0.5 <0.1(0.1) 5 0.1 (0.4)
[No. of house calls] 24.26 † 25 0.7 (1.4) 23 0.7 (1.5) 0 0 (0) 1 <0.1 (0.1) 24 0.7 (1.5)
Obstetrican/Gynaecologist [No. of consults] 58.29 † 15 0.2 (0.5) 15 0.2 (0.5) 20 0.3 (0.8) 21 0.3 (0.8) 29 0.5 (1.0)
[No. of tel. consults] 29.15 † 2 <0.1 (0.1) 4 0.1 (0.3) 1 <0.1 (0.1) 1 <0.1 (0.1) 1 <0.1 (0.1)
Other Medical specialist [No. of consults] 58.29 † 2 <0.1 (0.3) 4 0.1 (0.4) 12 0.3 (1.0) 14 0.3 (0.8) 14 0.3 (1.1)
[No. of tel. consults] 29.15 † 1 <0.1 (0.9) 1 <0.1 (0.1) 4 0.1 (0.6) 2 0.1 (0.4) 4 0.1 (0.5)
Hospitalizations [Length of stay in days] 350.80 † 18 0.6 (1.7) 17 0.6 (1.8) 2 0.1 (0.5) 2 0.1 (0.5) 20 0.7 (1.8)
Uncomplicated delivery [Length of stay in days] ... 8 2.7 (1.6) 6 2.4 (2.0) ... ... ... ... 6.9 0.2 (0.8)
OB-GYN-assisted [Length of stay in days] ... 0 0 (0) 1 11 (1.4) ... ... ... ... 0.2 <0.1 (0.6)
C-Section [Length of stay in days] ... 4 5.1 (1.3) 5 4.1 (1.2) ... ... ... ... 5.3 0.2 (1.1)
Peri-partum complications [Length of stay in days] ... 6 3.4 (3.0) 6 3.4 (3.1) <1 0.2 (1.1) 1 0.2 (1.1) 6.2 0.2 (1.0)
Other post-partum complications [Length of stay in days] ... 0 0 (0) 0 0 (0) 1 <0.1 (0.4) 2 <0.1 (0.4) 1.7 0.1 (0.5)
Psychologist [No. of sessions] 76.90 † 0 0 <1 <0.1 (0.1) 4 0.2 (1.5) 1 0.05 (0.59) 3 0.1 (1.1)
Other psych specialists [No. of sessions] Variable ‡, § 1 <0.1 (0.1) 1 <0.1 (0.1) 2 0.1 (0.5) 2 0.1 (0.7) 3 0.1 (0.6)
Physical therapist [No. of sessions] 23.68 † 2 0.1 (0.5) 5 0.1 (0.9) 18 1.5 (4.6) 11 0.8 (3.1) 15 1.2 (4.1)
[No. of fitness sessions] 13.20 ‡ 0 0 (0) 0 0 (0) 1 <0.1 (0.4) 1 0.1 (0.7) 1 0.1 (0.5)
Manual therapist [No. of sessions] 32.75 ‡ 0 0 (0) 0 0 (0) 5 0.2 (0.8) 2 0.1 (0.9) 3 0.1 (0.9)
Exercise therapist-Mensendieck [No. of sessions] 23.94 † 1 <0.1 (0.2) 2 <0.1 (0.4) 3 0.1 (1.2) 3 0.4 (2.3) 3 0.3 (2.0)
[No. of fitness sessions] 11.60 ‡ 0 0 (0) 1 <0.1 (0.3) 0 0 (0) 0.5 0.2 (2.6) <1 0.1 (2.0)
Other paramedical professionals [No. of sessions] Variable § 0 0 (0) 1 <0.1 (0.4) 5 0.2 (0.9) 2 0.1 (1.2) 4 0.2 (1.1)
Medications [% ] Variable ¶ 64 66 ... ... 75
Maternity aid [Hours] 31.06 † 97 40.0 (19.5) 98 39.2 (19.1) ... ... ... ... 98 39.6 (19.3)
Professional home/family care [Hours] Variable † 2 0.4 (3.6) 2 0.5 (4.0) 0 0 (0) 0.5 0.1 (1.2) 2 0.4 (3.5)
OTHER SECTOR
Occupational health physician [No. of consults] 34.01 § <1 <0.1 (0.1) 0 0 (0) 8 0.2 (0.8) 7 0.1 (0.4) 7 0.2 (0.6)
[No. of tel. consults] 11.34 § 1 <0.1 (0.1) 1 <0.1 (0.1) 5 0.1 (0.5) 7 0.1 (0.5) 6 0.1 (0.5)
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Table 2 List of resources with respective price weights, observed resource use for each group during the pre- and post-intervention periods, and pooled
values for the total study population during the first 52 week post-partum period (Continued)
Occupational consultant/nurse [No. of consults] Variable § 0 0 (0) 0 0 (0) 0.5 <0.1 (0.1) 0.5 <0.1 (0.1) <1 <0.1 (0.1)
[No. of tel. consults] Variable § 0 0 (0) 0 0 (0) 0.5 <0.1 (0.1)) 1 <0.1 (0.1) 1 <0.1 (0.1)
Employer-covered fitness [No. of sessions] Variable § 0 0 (0) 0 0 (0) 0 0 (0) 0.5 0.1 (2.1) <1 0.1 (1.5)
All alternative care providers [No. of sessions] Variable § 2 <0.1 (0.1) 2 <0.1 (0.1) 3 0.1 (0.8) 4 0.1 (0.8) 4 0.1 (0.8)
PATIENT & FAMILY
Extra paid household help [Hours] 8.64 † 2 0.5 (6.5) 3 0.3 (1.9) 11 1.5 (6.4) 9 1.3 (6.2) 11 1.6 (6.7)
Extra day care [Hours] 5.63 § 1 0.1 (6.5) 1 0.2 (3.3) 3 0.5 (3.4) 2 0.2 (1.5) 3 0.5 (3.7)
Partner [Hours] 8.64 † 52 27.2 (43.3) 51 28.3 (45.6) 31 13.1 (32.3) 19 18.3 (59.1) 58 42.5 (74.2)
Family/friends/volunteers [Hours] 8.64 † 31 35 11.7 (25.4) 27 6.5 (21.6) 21 6.6 (22.2) 43 15.4 (33.5)
Sport or physical fitness activity [%] Variable § 6 ... 6 ... 31 ... 30 ... 31 ...
PRODUCTIVITY LOSS
Sick leave from paid work [Hours] 31.72 ** ... ... ... ... 41 20.5 (60.6) 45 19.8 (49.0) 43 20.4 (55.4)
Work presenteeism [Hours] 31.72 ** ... ... ... ... 58 22.1 (35.2) 57 20.6 (29.8) 58 21.7 (32.7)
Total productivity loss [Hours] ... ... ... ... ... 71 42.6 (76.2) 73 42.3 (64.6) 72 42.5 (70.3)
* Percent utilization and mean resource use in the pre-intervention period was based on available cases. Corresponding figures for during the post-intervention period were based on complete cases; The sample
sizes for the STC and CP groups were 200 and 210, respectively. Pooled values were based on complete cost data: note that the sample sizes for the calculations varied because maternity aide care use was only
measured during the first of 9 possible measurement moments, sick leave and work presenteeism during seven of 9 possible measurement moments and the remaining resource use at all 9 possible measurement
moments during the 52-week follow-up. The sample size for maternity care aide use was N = 527, for sick leave from paid work and work presenteeism N = 424, and for the remaining types of resource use N =
418.
Price weight sources: † Dutch guidelines for costing studies; ‡Dutch Central Organization for Health Care Charges (CTG); § Respective providers or professional organizations; ¶ Royal Dutch Society for Pharmacy; **
Weighted average for women aged 19-45 years calculated from the Dutch guidelines for costing studies.
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comparable to 2005-2007 national figures, 70% and
29%, respectively [30]. The utilization results suggest
that access to health care and use of services following
childbirth is good. Nearly 100% of the women received
help from a maternity aid. Also, informal care by part-
ners, family, friends and volunteers plays a consider-
able role. Work presenteeism accounted for 50% of the
total productivity loss.
Strengths & limitations
A key strength of the study is that it is the first to inves-
tigate the cost-utility of interventions for post-partum
occupational health problems. This also underscores the
need for further research to identify cost-effective ways
to prevent sick leave and improve quality of life in
working mothers following childbirth. Additional
strengths include the use of a randomized controlled
trial design, with randomization at the supervisor-level
to prevent contamination; and a good follow-up rate in
which only 10% were lost-to-follow-up.
Main limitations are risks for selection bias, limited
generalizability and the logic of the intervention. With
regards to selection bias, there are two considerations.
First, we had difficulty recruiting companies to partici-
pate in this study. Participation may be reflective of the
degree of problem recognition within the company, and
in turn be reflective of the current workplace culture,
policies for maternal health issues, workers’ health and
sick leave. As such, the participating companies may
represent an optimal setting and any observed effect
could be an overestimation. However, we did not
observe an effect, therefore, selection bias in this sense
is not likely. Second, the women in the study had higher
levels of education compared to the general Dutch
female population. Higher levels of education are asso-
ciated with higher socioeconomic status, and better
post-partum health outcomes have been reported for
such groups of women [31]. It is unclear if the interven-
tion would have been more effective in a population
with a lower level of education.
The generalizability of the results may be limited by
differences in social context between The Netherlands
and other countries. For example, the length of mater-
nity leave in The Netherlands is 16 weeks with full pay,
whereas mothers in the UK are entitled to 52 weeks of
paid and unpaid leave [32]. In the USA, paid maternity
leave is not standard: among the best U.S. employers,
7% did not offer any paid leave, 17% between 1-4 weeks,
48% between 5-8 weeks, 20% 9-12 weeks and 8% more
than 12-weeks [33]. Also, differences in the organization
of primary and occupational health care, and the older
average age of Dutch women giving birth may result in
different patterns of resource use [34].
Other differences may be related to labour participa-
tion. In general, the characteristics of Dutch female
labour participation is comparable to many countries.
The Dutch female participation rate (59.2%) is slightly
Table 3 Respective group mean costs and mean cost differences during the post-intervention period (from 6-52 weeks
post-partum), and pooled totals for the first 52-weeks post-partum (including 1st 6-weeks post-partum) based on
imputed data and reported in 2006 Euros
Components STC* CP* Mean difference Pooled†
Mean (S.D.) Mean (S.D.) (95% CI) Mean (95% CI)
Health care sector 199 (375) 169 (326) 30 (-32; 99) 1707 (1613; 1765)
Other sectors 11 (39) 10 (51) 1 (-8; 9) 11 (8; 16)
Patient/family 273 (603) 274 (616) -1 (-121; 127) 608 (528; 690)
Sick leave 662 (1682) 625 (1655) 37 (-252; 334) 643 (506; 821)
Work presenteeism 765 (1164) 655 (944) 109 (-66; 298) 709 (615; 804)
Total productivity loss 1427 (2297) 1281 (2084) 146 (-228; 528) 1352 (1158; 1561)
Total costs 1911 (2867) 1734 (2644) 177 (-293; 678) 3678 (3386; 3951)
* STC = Supervisor telephone contact; CP = Common Practice.
† Pooled mean costs for health care sector and patient/family are higher than the mean group values during follow-up because the pooled means include costs
during the first 6-weeks post-partum. During the first 6-weeks post-partum (i.e. pre-intervention phase), health care resource use and informal care by partner
and family were high and similar between groups.
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Figure 2 Cost-utility plane illustrating the distribution of the
joint cost-QALY pairs from the main analysis and the mean
ICUR ( - 25,440).
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higher than the world average (51.9%) but similar to, for
example, Sweden, Canada, United States and Australia.
The Dutch rate is lower than the rates in, for example,
Iceland, Rwanda, Kenya and Cambodia (>70%), and it is
higher than the rates in, for example, Belgium, Italy,
Japan and Turkey (< 50%) [35]. The percentage of
Dutch women working in non-agricultural sectors
(45.7%) is higher than the world average (36.9%), how-
ever, in line with countries around the world such as
the United States, Canada, Belgium, Norway, Thailand,
Argentina and the Central African Republic [36]. The
majority of the participants in our study worked in the
health care sector, which worldwide, traditionally has a
predominantly female workforce.
The intervention was based on the logic that early
identification of clinical post-partum morbidities by the
supervisor telephone contact would lead to timely invol-
vement of occupational health to identify potential bar-
riers and corresponding solutions for returning to work
given the clinical post-partum morbidity. This logic
behind linking clinical post-partum morbidities with
occupational health is that occupational health has a key
role in maintaining a link to the workplace, which facili-
tates return-to-work. The one-time phone call served as
a starting point for preventative actions that could be
initiated in the workplace by the occupational health
physician in order to optimalize return-to-work.
Methodological considerations
Reasons for the lack of effect may be poor conceptuali-
zation of the intervention, low intensity of the interven-
tion, use of parental leave, and characteristics of the
study population. First, poor conceptualization is unli-
kely. Recently, Kant et al. reported that structured early
consultation with the occupational physician reduced
sick leave in a high risk population of office workers
[37]. Earlier involvement of occupational physicians was
the aim of the intervention.
Second, it is possible that intensity of the intervention
was too low. The one-time phone call at 6-weeks may
have been insufficient as new problems may arise
between 6-weeks and the official end of the maternity
leave. Follow-up contact, for example, at 8 or 9-weeks
or at biweekly intervals until expected return-to-work,
may be improvements.
Third, in The Netherlands, all working mothers are
eligible to take complete or partial parental leave follow-
ing maternity leave. It is possible that parental leave
may mask sick leave. However, the numbers postponing
return-to-work after maternity leave by using complete
parental leave were comparable between the groups
(STC = 17%; CP = 20%). Also, given that the women
were eligible for sick leave benefits up to 2-years, we do
not think the women who took complete parental leave
did so as a substitute for sick leave. However, the use of
partial parental leave may help women make the transi-
tion from maternity leave to return-to-work as usual
and as such, have a preventative effect on sick leave or
work presenteeism. Proportions of women in both
groups taking parental leave at 18-, 24- and 52-weeks
post-partum were comparable: STC = 21%, 25% and
18%; CP = 24%, 23% and 15%.
Last, the most probable reason for lack of effect likely
relates to the characteristics of the study population. The
women in this study represented a healthy group of
working mothers: utilities of the women were above 0.9
at each measurement moment and health care consump-
tion throughout the follow-up period was low. Further-
more, the sick leave rates of the study population were
lower than those reported in the literature used to con-
ceptualize the intervention. In our study, only 2% of the
women took sick leave at the end of their maternity leave
Table 4 Mean cost differences (ΔC), mean effect differences (ΔE), incremental cost-utility ratios and distribution of the
joint cost-effect pairs in the cost-utility plane from the main cost-utility analysis and corresponding three sensitivity
analyses (SA1, SA2 and SA3)
Analysis* Sample size ΔC (95% CI) ΔE (95% CI) ICUR Distribution in CU-plane
STC CP NE† SE‡ SW§ NW¶
Main 260 272 177 (-293; 678) -0.007 (-0.023; 0.009) -25,440 ** 10% 9% 14% 67%
SA1 260 272 186 (-350; 751) -0.007 (-0.023; 0.009) -26,774 ** 10% 9% 16% 65%
SA2 252 260 -194 (-295; 751) -0.005 (-0.021; 0.117) -42,569 ** 17% 13% 10% 59%
SA3 200 210 41 (-404; 487) 0.001 (-0.017; 0.015) -40,939 ** 20% 25% 17% 38%
* In the main analysis, ΔE = mean difference in QALY, ΔC = mean difference in total costs in which the productivity loss costs were estimated by the FCM; in
SA1, ΔC = mean difference in total costs in which the productivity loss costs were estimated by the HCA; SA2 is a repetition of the main analysis in which
women who became pregnant a second time during follow-up (N = 20) were excluded; SA3 is a repetition of the main analysis using only the complete cases.
† Refers to the northeast quadrant of the CU-plane, which indicates that STC is more effective and more costly than CP.
‡ Refers to the southeast quadrant of the CU-plane, which indicates that STC is more effective and less costly than CP.
§ Refers to the southwest quadrant of the CU-plane, which indicates that STC is less effective and less costly than CP.
¶ Refers to the northwest quadrant of the CU-plane, which indicates that STC is less effective and more costly than CP.
** All of these negative incremental cost-utilty ratios (ICURs) were located in the NW quadrant, along with the majority of joint cost-effect pairs, indicating that
the STC was less effective and more costly than CP.
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versus 29%. This unexpected result suggests that there
may not have been a problem upon which to intervene.
With regards to the cost description, we excluded par-
ental leave. However, parental leave may be considered
another form of productivity loss during the first
52-weeks post-partum. In our study, 45% of the subjects
took either complete or partial parental leave, with the
mean number of parental leave hours taken in the
52-weeks post-partum being 117 (S.D. = 168). If paren-
tal leave is considered in the total costs, then parental
leave would represent the main cost driver and account
for 52% of the total costs.
We conducted our economic evaluation from a socie-
tal perspective. However, additional analyses from a spe-
cific stakeholder perspective can be informative and
desirable. In The Netherlands, the company is a key sta-
keholder as it has the responsibility to pay for interven-
tions as well as an opportunity to gain in terms of
decreased sick leave and work presenteeism. With
respect to this study, a cost analysis from a company’s
perspective would compare the interventions costs (i.e.
other sector costs consisting of occupational health and
supervisor time) to the costs of productivity loss (i.e. all
work presenteeism and sick leave not subsequent to
maternity leave) between the groups. The mean inter-
vention costs were €1 higher in the STC group as were
the mean work presenteeism costs (€109; see Table 3).
Estimation of mean group differences in sick leave costs
limited to sick leave not subsequent to maternity leave
was also higher in the STC group (€89; 95% CI: -192;
379). Therefore, from a company’s perspective, imple-
mentation of STC is not warranted.
In occupational health care, the scope of productivity
loss has traditionally focussed solely on sick leave. In
recent years, decreased productivity while at work, i.e.
work presenteeism has received more attention. How-
ever, little is known about work presenteeism following
childbirth. In this study, 58% of the women reported
work presenteeism and the contribution of sick leave
and work presenteeism to total productivity loss hours
was roughly 50:50. Our finding that work presenteeism
was a common problem is in line with other studies
investigating other working populations and health pro-
blems. For example, Aronsson et al. [8] found that 37%
of the Swedish workforce experienced work presentee-
ism. Among workers with high physical load jobs and
health problems, 50% reported work presenteeism [38].
That work presenteeism can represent a considerable
proportion of total productivity loss, is in line with find-
ings from Burton et al. in which the ratio of sick leave:
work presenteeism was 40:60 [39]. As such, future stu-
dies on return-to-work following childbirth should
include work presenteeism.
Conclusions
In this study, very few women had post-partum health
problems that acted as barriers to return-to-work. In this
healthy population, early supervisor telephone contact
during maternity leave was not cost-effective compared
to common practice and widespread implementation is
not warranted. The cost-utility of early supervisor tele-
phone contact should be evaluated in a high-risk popula-
tion and studied in other socio-political systems. The
lack of comparable studies underscores that return-
to-work following childbirth is under-researched. Tradi-
tionally, the focus of return-to-work interventions has
been on sick leave. Work presenteeism may also form a
substantial portion of total productivity loss and should
be considered in future research.
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